279
Participants
Start Date
July 31, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
Canagliflozin 50 mg
One canagliflozin 50-mg capsule taken orally twice daily with a meal for 18 weeks
Placebo
1 placebo capsule taken orally twice daily with a meal for 18 weeks
Canagliflozin 150 mg
1 canagliflozin 150-mg capsule taken orally twice daily with a meal for 18 weeks
Metformin
The patient's stable daily dose of Metformin background therapy should be continued throughout the study.
Little Rock
National City
Spring Valley
Bradenton
Marianna
Savannah
Avon
Valparaiso
Madisonville
Metairie
Charlotte
Columbus
Mason
Perrysburg
Tulsa
Yukon
Oregon City
Pittsburgh
East Providence
Nashville
Houston
Pearland
San Antonio
Bountiful
Virginia Beach
Milwaukee
St. John's
Halifax
Brampton
Toronto
Saskatoon
Beroun
Olomouc
Ostrava
Pardubice
Písek
Prague
Znojmo
Aguascalientes
Guadalajara, Jalisco.
Monterrey
Tampico
Bacau
Brasov
Bucharest
Cluj-Napoca
Galati
Târgu Mureş
Kursk
Moscow
Saint Petersburg
Samara
Saratov
Tyumen
Voronezh
Banská Bystrica
Bratislava
Košice
Prešov
Šahy
Trebišov
Janssen Research & Development, LLC
INDUSTRY